Shield Therapeutics plc (STX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 09:29AM GMT. Market open.
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 26.38M |
| Enterprise value | 23.98M |
| Trailing P/E | 53.33 |
| Forward P/E | 65.36 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.37 |
| Price/book (mrq) | 0.81 |
| Enterprise value/revenue | 7.81 |
| Enterprise value/EBITDA | -1.12 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.24 |
| 52-week change 3 | -73.08% |
| S&P500 52-week change 3 | -13.53% |
| 52-week high 3 | 52.00 |
| 52-week low 3 | 5.52 |
| 50-day moving average 3 | 9.26 |
| 200-day moving average 3 | 12.70 |
Share statistics
| Avg vol (3-month) 3 | 459.76k |
| Avg vol (10-day) 3 | 389k |
| Shares outstanding 5 | 257.39M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 103.48M |
| % held by insiders 1 | 41.88% |
| % held by institutions 1 | 11.46% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2021 |
| Most-recent quarter (mrq) | 30 Jun 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -783.09% |
Management effectiveness
| Return on assets (ttm) | -34.05% |
| Return on equity (ttm) | -57.03% |
Income statement
| Revenue (ttm) | 3.07M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | 322.20% |
| Gross profit (ttm) | 539k |
| EBITDA | -22.9M |
| Net income avi to common (ttm) | -23.84M |
| Diluted EPS (ttm) | -8.70 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.4M |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.60 |
| Book value per share (mrq) | 0.15 |
Cash flow statement
| Operating cash flow (ttm) | -17.46M |
| Levered free cash flow (ttm) | -15.29M |
© 2022 Yahoo. All rights reserved.
